• Register
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.


Leaving Community

Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.


Targeted oncogene activation by site-specific recombination in transgenic mice.

An efficient and accurate method for controlled in vivo transgene modulation by site-directed recombination is described. Seven transgenic mouse founder lines were produced carrying the murine lens-specific alpha A-crystallin promoter and the simian virus 40 large tumor-antigen gene sequence, separated by a 1.3-kilobase-pair Stop sequence that contains elements preventing expression of the large tumor-antigen gene and Cre recombinase recognition sites. Progeny from two of these lines were mated with transgenic mice expressing the Cre recombinase under control of either the murine alpha A-crystallin promoter or the human cytomegalovirus promoter. All double-transgenic offspring developed lens tumors. Subsequent analysis confirmed that tumor formation resulted from large tumor-antigen activation via site-specific, Cre-mediated deletion of Stop sequences.

Pubmed ID: 1631115


  • Lakso M
  • Sauer B
  • Mosinger B
  • Lee EJ
  • Manning RW
  • Yu SH
  • Mulder KL
  • Westphal H


Proceedings of the National Academy of Sciences of the United States of America

Publication Data

July 15, 1992

Associated Grants


Mesh Terms

  • Animals
  • Antigens, Polyomavirus Transforming
  • Base Sequence
  • Cataract
  • DNA Nucleotidyltransferases
  • Eye Neoplasms
  • Integrases
  • Mice
  • Mice, Transgenic
  • Molecular Sequence Data
  • Oligodeoxyribonucleotides
  • Oncogenes
  • Recombination, Genetic
  • Regulatory Sequences, Nucleic Acid
  • Viral Proteins